Takara Bio Inc.
Investor Relations
Financial Data
Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Net Sales

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	46,086	67,699	78,142	43,505	45,039	-
3Q	29,549	45,659	60,206	29,734	29,282	-
2Q	17,393	31,551	32,587	19,116	19,758	-
1Q	6,938	15,272	14,102	9,176	8,493	9,266

Operating Income

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	13,952	28,902	20,541	3,003	2,263	-
3Q	8,791	19,926	19,403	336	-1,473	-
2Q	3,736	14,105	10,870	1,410	417	-
1Q	693	8,504	4,537	423	-1,634	-1,796

Ordinary Income

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	14,159	28,459	20,682	3,405	2,592	-
3Q	8,919	20,154	19,480	586	-1,255	-
2Q	3,820	14,241	10,955	1,598	549	-
1Q	745	8,579	4,593	509	-1,498	-1,838

Profit Attributable to Owners of Parent

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	9,547	19,849	16,012	1,480	1,041	-
3Q	5,726	14,364	14,595	154	-1,378	-
2Q	2,274	10,009	8,538	1,084	513	-
1Q	404	6,025	3,907	319	-1,047	-1,511

Net Income Per Share

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	79.29	164.84	132.97	12.30	8.65	-
3Q	47.56	119.29	121.21	1.28	-11.45	-
2Q	18.89	83.12	70.91	9.00	4.26	-
1Q	3.36	50.04	32.45	2.65	-8.70	-12.55

Total Assets

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	89,750	115,712	129,202	121,252	125,334	-
3Q	83,846	106,116	128,140	123,087	119,301	-
2Q	77,343	104,777	120,023	123,283	125,280	-
1Q	73,593	99,658	111,488	120,662	121,752	129,943

Net Assets

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	74,302	96,064	112,454	111,784	115,849	-
3Q	70,568	89,455	114,711	112,529	109,003	-
2Q	67,236	84,766	106,949	112,130	116,155	-
1Q	65,580	80,586	98,425	108,207	111,516	109,436

Capital Adequacy Ratio

	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
FY	82.7	82.9	86.9	92.0	92.2	-
3Q	84.0	84.1	89.3	91.2	91.1	-
2Q	86.8	80.7	88.9	90.7	92.4	-
1Q	89.0	80.7	88.1	89.5	91.3	84.0

CLOSE
MENU

サイト内検索

footer-content

menu

JA
EN

contact

gnavi-box